Central Diabetes Insipidus: Clinical Trials

2 trials for Central Diabetes Insipidus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Central Diabetes Insipidus: new trials by email Literature Review of Central Diabetes Insipidus trials Research Report on Central Diabetes Insipidus

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
Experimental: GLP1-RA (exenatide) administration, Control: Placebo administration - Hypopituitarism, Central Diabetes Insipidus
Phase 4CompletedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau422021-09-132026-01-20
Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)
Experimental: CRH administration, Control: Placebo administration - Hypopituitarism, Central Diabetes Insipidus
Phase 4CompletedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau522021-07-062024-04-03

Narrower conditions

Combined Pituitary Hormone Deficiency (2)  ·  Diabetes Insipidus, Neurogenic (2)  ·  Hypopituitarism (2)  ·  Hypothalamic Diseases (2)  ·  Mental Disorders (2)  ·  Pituitary Diseases (2)  ·  Social Isolation (2)  ·  Diabetes Insipidus (1)

Broader conditions

Behavior (2)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Nervous System Diseases (2)  ·  Social Behavior (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Diabetes Insipidus (1)

Interventions

Exenatide (1)  ·  Organization and Administration (1)  ·  Sodium Chloride (1)

Sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (2)

Countries

Spain (2)

Top investigators

Anna Aulinas, MD PhD (2)

Results publications

PMID 39824923